Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: Winfastorlose who wrote (1318048)	9/6/2021 1:58:12 AM
From: Bonefish	Read Replies (1) \| Respond to of 1570711

That ought to scare the chit out of anyone vaxxed.

To: Winfastorlose who wrote (1318048)	9/6/2021 8:57:26 AM
From: FJB	1 Recommendation Recommended By Winfastorlose Respond to of 1570711

Study: Covid Shot ENHANCES Delta Infectivity According to the U.S. Centers for Disease Control and Prevention, people who got the COVID shot early are now at increased risk for severe COVID disease This may be a sign that antibody dependent enhancement (ADE) is occurring, or it may simply indicate that the protection offered is limited to a few months, at best Recent research warns the Delta variant “is posed to acquire complete resistance to wild-type spike vaccines.” This could turn into a worst-case scenario that sets up those who have received the Pfizer shots for more severe illness when exposed to the virus To “stay ahead of the virus,” the Biden administration is now considering recommending a booster shot five months after the initial two doses rather than waiting eight months, as previously suggested Israeli data show Pfizer’s shot went from a 95% effectiveness at the outset to 39% by late July 2021, when the Delta strain became predominant. The U.S. Food and Drug Administration’s expectation for any vaccine is an efficacy rate of at least 50% compared to placebo